TPO and hematocrit: Ostowska et al found that in HT patients, after 3 months of GFD, body weight, BMI, body fat percentage, TSH, anti‐TPO levels, and FT4 hormone levels of the intervention group decreased significantly compared with controls (Ostrowska et al., 2021).